Home › Funds › Swiss Life Asset Management Ltd › GILD

Swiss Life Asset Management Ltd position in GILD

GILEAD SCIENCES INC · Health Care

Swiss Life Asset Management Ltd reported holding 532,475 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$79.4M, representing 0.34% of its reported portfolio and ranking #45 among its reported holdings. Swiss Life Asset Management Ltd has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)532.48K sh
Reported value held$79.37M
Portfolio Weight0.34%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Swiss Life Asset Management Ltd's GILD position evolved

Swiss Life Asset Management Ltd first disclosed a stake in GILD in Q3 2023 at 520,274 shares (US$39.0M). The position peaked in Q3 2026 at 532,475 shares, worth US$79.4M. Across 13 filings, Swiss Life Asset Management Ltd increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 532,475 shares valued at US$79.4M — an increase of 6,820 shares quarter over quarter.. Notable position changes include a 35% trim in Q4 2025 (shares rose 14% over the following quarter), a 35% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 520.27K $38.98M New
Q4 2023 455.18K $36.90M Reduce
Q1 2024 456.58K $33.44M Hold
Q2 2024 434.49K $29.81M Reduce
Q3 2024 502.55K $42.12M Add
Q4 2024 539.53K $49.81M Add
Q1 2025 558.88K $62.62M Add
Q2 2025 537.46K $59.59M Reduce
Q3 2025 569.27K $63.19M Add
Q4 2025 371.37K $45.58M Reduce
Q1 2026 389.48K $54.28M Add
Q2 2026 525.65K $66.41M Add
Q3 2026 532.48K $79.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Swiss Life Asset Management Ltd held GILD?

Swiss Life Asset Management Ltd has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Swiss Life Asset Management Ltd's current position in GILD?

As of Q3 2026, Swiss Life Asset Management Ltd holds 532.48K shares of GILD (GILEAD SCIENCES INC), valued at $79.37M, representing 0.34% of its reported portfolio and ranking #45.

Has Swiss Life Asset Management Ltd been buying or selling GILD?

In the latest 13F filing (Q3 2026), Swiss Life Asset Management Ltd increased its position in GILD. The position peaked in Q3 2026 at 532.48K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.